LumiThera Inc.: LumiThera Secures Financing to Support Commercial Activities
SEATTLE, March 10, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the
Source: finanznachrichten.de